GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510 | +41.7% | 250 | 0.0% | 0.00% | – |
| Q2 2023 | $360 | -38.8% | 250 | -28.6% | 0.00% | – |
| Q1 2023 | $588 | +48.5% | 350 | 0.0% | 0.00% | – |
| Q4 2022 | $396 | – | 350 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 350 | +40.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -75.0% | 250 | -80.0% | 0.00% | -100.0% |
| Q2 2020 | $4,000 | +33.3% | 1,250 | -26.5% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -50.0% | 1,700 | -22.7% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | -25.0% | 2,200 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $8,000 | -11.1% | 2,200 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $9,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $248,617 | 0.07% |
| Geneos Wealth Management Inc. | 417,350 | $801,312 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $23,040 | 0.02% |
| RETIREMENT GUYS FORMULA LLC | 11,500 | $22,080 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $36,981 | 0.01% |
| OSAIC HOLDINGS, INC. | 3,275,192 | $6,288,345 | 0.01% |
| Traynor Capital Management, Inc. | 34,707 | $66,638 | 0.01% |
| Atria Wealth Solutions, Inc. | 259,800 | $498,816 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $9,569 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $353,016 | 0.01% |